Advanced search
Publication Cover
Hematology Volume 20, 2015 - Issue 3
Submit an article Journal homepage
1,665
Views
14
CrossRef citations to date
0
Altmetric
Hemophilia

Adherence to clotting factors among persons with hemophilia A or B

Edward P. ArmstrongCorrespondence[email protected]
,
Daniel C. Malone
,
Sangeeta KrishnanBiogen IdecWeston, MA, USA
&
Maj Jacob WesslerDepartment of PediatricsNaval Medical Center Portsmouth, Portsmouth, VA, USA
Pages 148-153 | Published online: 07 Jul 2014

References

  • Mannucci PM, Tuddenham EG. The hemophilias – from royal genes to gene therapy. N Engl J Med. 2001;344(23):1773–9.
  • Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet 2003;361(9371):1801–9.
  • Evatt BL. Demographics of hemophilia in developing countries. Semin Thromb Hemost. 2005;31(5):489–94.
  • Rodriguez-Merchan EC. Management of musculoskeletal complications of hemophilia. Semin Thromb Hemost. 2003;29(1):87–96.
  • Valentino LA. Secondary prophylaxis therapy: what are the benefits, limitations and unknowns? Haemophilia 2004;10(2):147–57.
  • Kilcoyne RF, Nuss R. Radiological assessment of haemophilic arthropathy with emphasis on MRI findings. Haemophilia 2003;9( Suppl 1):57–64.
  • Zhou ZY, Wu J, Baker J, Curtis R, Forsberg A, Huszti H, et al. Haemophilia utilization group study – Part Va (HUGS Va): design, methods and baseline data. Haemophilia 2011;17(5):729–36.
  • Manco-Johnson MJ, Abshire TC, Shapiro AD, Riske B, Hacker MR, Kilcoyne R, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535–44.
  • Valentino LA, Pipe SW, Tarantino MD, Ye X, Xiong Y, Luo MP. Healthcare resource utilization among haemophilia A patients in the United States. Haemophilia 2012;18(3):332–8.
  • Blanchette VS. Prophylaxis in the haemophilia population. Haemophilia 2010;16( Suppl 5):181–8.
  • Walsh CE, Valentino LA. Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices. Haemophilia 2009;15(5):1014–21.
  • Tagliaferri A, Franchini M, Coppola A, Rivolta GF, Santoro C, Rossetti G, et al. Effects of secondary prophylaxis started in adolescent and adult haemophiliacs. Haemophilia 2008;14(5):945–51.
  • Iorio A, Marchesini E, Marcucci M, Stobart K, Chan AK. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. Cochrane Database Syst Rev. 2011;(9):CD003429.
  • Shapiro A, Gruppo R, Pabinger I, Collins PW, Hay CR, Schroth P, et al. Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia A. Expert Opin Biol Ther. 2009;9(3):273–83.
  • Berntorp E, Astermark J, Bjorkman S, Blanchette VS, Fischer K, Giangrande PL, et al. Consensus perspectives on prophylactic therapy for haemophilia: summary statement. Haemophilia 2003;9( Suppl 1):1–4.
  • du Treil S, Rice J, Leissinger CA. Quantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia population. Haemophilia 2007;13(5):493–501.
  • Council MaSA. MASAC recommendation concerning prophylaxis (regular administration of clotting factor concentrate to prevent bleeding): National Hemophilia Foundation. 2007 [2013 Jan 3]. MASAC document #179. Available from: http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF. aspx?menuid=57&contentid=1007.
  • Duncan N, Kronenberger W, Roberson C, Shapiro A. VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia. Haemophilia 2010;16(2):247–55.
  • De Moerloose P, Urbancik W, Van Den Berg HM, Richards M. A survey of adherence to haemophilia therapy in six European countries: results and recommendations. Haemophilia 2008;14(5):931–8.
  • Duncan N, Shapiro A, Ye X, Epstein J, Luo MP. Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States. Haemophilia 2012;18(5):760–5.
  • Epstein J, Xiong Y, Woo P, Li-McLeod J, Spotts G. Retrospective analysis of differences in annual factor VIII utilization among haemophilia A patients. Haemophilia 2012;18(2):187–92.
  • Lindvall K, Colstrup L, Wollter IM, Klemenz G, Loogna K, Gronhaug S, et al. Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia. Haemophilia 2006;12(1):47–51.
  • Hacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia 2001;7(4):392–6.
  • Thornburg CD. Physicians' perceptions of adherence to prophylactic clotting factor infusions. Haemophilia 2008;14(1):25–9.
  • Thornburg CD. Prophylactic factor infusions for patients with hemophilia: challenges with treatment adherence. J Coagul Disord. 2010;2(1):9–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.